1800-272-662
Shopping Cart 0
countryflagAU
Login

Trulieve Cannabis Corp

Healthcare US TCNNF

6.3USD
-0.1(1.56%)

Last update at 2026-03-10T19:58:00Z

Day Range

6.106.54
LowHigh

52 Week Range

3.427.84
LowHigh

Fundamentals

  • Previous Close 6.40
  • Market Cap937.76M
  • Volume34577
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA229.92M
  • Revenue TTM1162.28M
  • Revenue Per Share TTM6.15
  • Gross Profit TTM 683.04M
  • Diluted EPS TTM-2.52

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -43.30000M 163.51M 157.45M 272.47M 71.73M
Minority interest 6.70M 0.59M - - -
Net income -246.10000M 18.03M 63.00M 178.03M 42.97M
Selling general administrative 454.60M 315.72M 155.45M 68.01M 29.19M
Selling and marketing expenses - - - - -
Gross profit 682.00M 566.13M 386.42M 362.28M 105.56M
Reconciled depreciation 119.40M 78.22M 30.19M 17.19M 3.11M
Ebit 133.76M 261.95M 224.04M 113.34M 35.09M
Ebitda 155.90M 276.51M 207.87M 302.47M 77.02M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 108.00M 202.32M 218.37M 285.88M 75.24M
Other operating expenses - - - - -
Interest expense 79.80M 34.79M 20.24M 12.82M 2.18M
Tax provision 161.80M 146.06M 94.45M 94.44M 28.76M
Interest income - - - - -
Net interest income -79.80000M -34.78700M -20.23700M -12.81647M -2.18365M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 161.82M 146.70M 94.45M 50.59M 22.15M
Total revenue 1239.80M 938.38M 521.53M 252.82M 102.82M
Total operating expenses 1131.80M 736.07M 303.17M -33.06168M 27.58M
Cost of revenue 557.80M 372.25M 135.12M -109.46630M -2.74604M
Total other income expense net -71.50000M -4.02400M -40.68000M -0.59375M -1.32791M
Discontinued operations -47.56200M -1.93900M -1.93900M -1.93900M -
Net income from continuing ops -205.10000M 17.45M 63.00M 178.03M 42.97M
Net income applicable to common shares -246.06400M 18.03M 63.00M 53.09M 10.89M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3399.00M 3410.87M 816.11M 590.89M 162.07M
Intangible assets 1012.60M 1117.98M 90.14M 23.50M 9.40M
Earning assets - - - - -
Other current assets 49.86M 27.54M 2.96M -0.00100M 29.64M
Total liab 1471.30M 1263.50M 368.21M 308.54M 57.85M
Total stockholder equity 1931.20M 2145.82M 447.90M 282.36M 104.22M
Deferred long term liab - - - - -
Other current liab 100.26M 55.73M 32.98M 29.15M 16.49M
Common stock - - - 62.56M 60.98M
Capital stock 0.00000M 0.00000M 0.00000M 62.56M 60.98M
Retained earnings -113.84300M 137.72M 119.69M 56.69M 27.61M
Other liab 265.14M 277.17M 19.36M 123.74M 9.88M
Good will 791.50M 765.36M 74.10M 7.32M -
Other assets 27.40M 81.95M 7.53M 0.95M 1.10M
Cash 212.30M 230.65M 146.71M 91.81M 24.43M
Cash and equivalents - - - - -
Total current liabilities 209.70M 169.45M 76.12M 52.67M 34.71M
Current deferred revenue - - - - -
Net debt 436.10M 248.79M - 41.43M -
Short term debt - - - 2.92M 7.43M
Short long term debt 12.50M 10.05M 14.01M 2.92M 7.43M
Short long term debt total - - - - -
Other stockholder equity - - 52.57M 15.02M 15.63M
Property plant equipment 974.56M 957.90M 381.02M 185.88M 70.79M
Total current assets 592.95M 524.93M 261.45M 165.47M 80.79M
Long term investments - - - - -
Net tangible assets 127.02M 299.22M 288.13M 99.19M 94.82M
Short term investments - - - - -
Net receivables 10.84M 19.94M 1.62M - -
Long term debt 635.90M 469.38M 4.00M 130.32M 12.65M
Inventory 297.81M 209.94M 98.31M 65.98M 53.91M
Accounts payable 16.41M 14.34M 9.25M 9.95M 10.46M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 15.40M 18.31M 3.94M 0.95M 1.10M
Deferred long term asset charges - - - - -
Non current assets total 2806.00M 2886.45M 550.96M 221.02M 81.28M
Capital lease obligations 380.90M 379.59M 150.59M 71.00M 0.95M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -215.05700M -215.18400M -174.65400M -74.07364M -52.96130M
Change to liabilities 1.55M -14.30100M 5.07M 14.56M 2.47M
Total cashflows from investing activities -215.05700M -215.18400M -174.65400M -94.67200M -51.05500M
Net borrowings 159.90M 64.64M 35.22M 142.02M 2.27M
Total cash from financing activities 177.80M 289.23M 129.91M 142.98M 50.56M
Change to operating activities 10.60M -33.10900M -18.24700M -3.98700M -2.64400M
Net income -246.06400M 18.03M 63.00M 53.09M 10.89M
Change in cash -14.22500M 86.39M 54.90M 67.38M 23.02M
Begin period cash flow 233.10M 146.71M 91.81M 24.43M 1.41M
End period cash flow 218.87M 233.66M 146.71M 91.81M 24.43M
Total cash from operating activities 23.10M 12.90M 99.64M 19.07M 23.52M
Issuance of capital stock 0.00000M 217.90M 83.23M 0.00000M 47.47M
Depreciation 185.57M 78.22M 35.14M 15.80M 3.11M
Other cashflows from investing activities 1.47M -3.84000M -3.84000M -0.00100M 0.00100M
Dividends paid - - - - -
Change to inventory -83.43000M -19.57300M -22.53400M -54.48100M -18.75100M
Change to account receivables -4.20600M -4.90100M 1.11M 1.11M 1.11M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.88200M -0.25100M -0.25100M -0.25100M -0.46100M
Change to netincome 139.32M 1.51M 38.55M 0.15M 14.52M
Capital expenditures 182.73M 306.12M 145.86M 74.88M 43.54M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -55.72700M -84.86300M -37.05200M -216.31764M -22.32720M
Stock based compensation 18.12M 9.25M 2.77M 0.00000M -
Other non cash items 78.51M 13.94M 2.89M 1.31M 1.17M
Free cash flow -161.48700M -283.98300M -42.30100M -51.19004M -20.46518M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TCNNF
Trulieve Cannabis Corp		 -0.1 1.56% 6.30 - 20.41 0.79 0.63 1.40 -25.9334
ZTS
Zoetis Inc		 -1.87 1.53% 120.49 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.56 2.23% 25.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.64 2.02% 128.01 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.14 0.77% 18.21 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, California, Maryland, Massachusetts, West Virginia, and Connecticut; and affiliated dispensaries in Pennsylvania. It also operated cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Massachusetts, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

Trulieve Cannabis Corp

6749 Ben Bostic Road, Quincy, FL, United States, 32351

Key Executives

Name Title Year Born
Ms. Kimberly Rivers Founder, Chairman & CEO 1978
Mr. Alex D'Amico CPA Chief Financial Officer 1975
Mr. Eric Raymond Powers III, J.D. Chief Legal Officer & Corp. Sec. 1969
Mr. Steven Mathew White Pres 1974
Ms. Rebecca L. Young VP & Chief Accounting Officer 1981
Mr. Nilyum Jhala Chief Technology Officer NA
Mr. Jason Barry Pernell Chief Information Officer 1978
Ms. Christine Hersey Director of Investor Relations NA
Mr. Robert Kremer Exec. Director of Corp. Communications NA
Ms. Victoria Walker Director of Marketing & Community Relations 1985

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.